---
title: Remifentanil
feed: show
notetype: feed
date: 08-07-2024
tags: #Drug, #clerkship 
---
# Remifentanil

## Description
- Ultra-short-acting synthetic opioid analgesic
- Used for pain management and as an adjunct to anesthesia
- Rapid onset and short duration of action

## Mechanism of Action
- Acts primarily on mu-opioid receptors in the brain and spinal cord
- Minimal or no activity on delta and kappa opioid receptors
- Rapidly metabolized by nonspecific esterases in blood and tissues

## Indications
- Induction and maintenance of general anesthesia
- Analgesia during short/intense surgical procedures
- MAC sparing agent

## Dosage
- **Bolus:**
  - 1 µg/kg IV bolus

- **Maintenance of anesthesia:**
  - 0.05 to 0.2 µg/kg/min IV infusion

- **Analgesia during surgery:**
  - 0.5 to 1 µg/kg IV bolus
  - Followed by an infusion of 0.05 to 0.2 µg/kg/min

## Contraindications
- Hypersensitivity to remifentanil or any of its components
- Patients not receiving appropriate respiratory support

## Side Effects
- Bradycardia
- Respiratory depression
- Hypotension
- Muscle rigidity -- particularly chest wall rigidity
- Nausea and vomiting

## References
1. [[@cullenBarashCullenStoelting2024 | Bruce F. Cullen, Bruce F. Cullen, Barash, Cullen, and Stoelting's clinical anesthesia, 2024]]



[^1]:
[^2]:
[^3]:
[^4]: